Search Results
197 items found for "fibrotic bone disease"
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
agonism at the GLP-1R represents a promising strategy for optimizing therapeutic outcomes in metabolic diseases
- 📰 GPCR Weekly News, March 20 to 26, 2023
Endocrinology, and Taste Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease
- 📰 GPCR Weekly News, August 28 to September 3, 2023
A case for (mutant) G protein-coupled receptors Reviews, GPCRs, and more RGS2 and female common diseases
- 📰 GPCR Weekly News, March 6 to 12, 2023
GPCRs in Neuroscience Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson's disease
- 📰 GPCR Weekly News, February 5 to 11, 2024
G-protein coupled receptor-mediated vasocontraction in rat coronary arteries GPCRs involved in metabolic diseases
- Molecular insights into regulation of constitutive activity by RNA editing 5HT2C serotonin receptor
Collectively, these findings reveal a unique hydrogen-bonding network located on intracellular loop 2
- Integrative model of the FSH receptor reveals the structural role of the flexible hinge region
major rearrangement of the HR seems implausible due to the tight arrangement and fixation by disulfide bonds
- 📰 GPCR Weekly News, January 8 to 14, 2024
more The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative diseases
- 📰 GPCR Weekly News, January 1 to 7, 2024
midgut development in Drosophila Structure, ligands, and roles of GPR126/ADGRG6 in the development and diseases
- 📰 GPCR Weekly News, April 10 to 16, 2023
Adhesion GPCRs Downstream signaling of the disease associated mutations on GPR56/ADGRG1.
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
screening of potential inhibitors of GPR52 using docking and biased sampling method for Huntington's disease
- GPCR Buzz of the Week | Sep 23 - 29, 2024
and design of 5-HT6 antagonists through assessment of ANN-QSAR models in the context of Alzheimer's disease
- 📰 GPCR Weekly News, January 22 to 28, 2024
Financial Results Novartis Automates New Radioligand Therapy Production Plant Novartis’ Lutathera reduces disease
- 📰 GPCR Weekly News, June 17 to 23, 2024
grandiflora against Candida auris FKBP12 Development and therapeutic perspectives of CXCR4 antagonists for disease
- 📰 GPCR Weekly News, March 13 to 19, 2023
and Immunology Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases
- 📰 GPCR Weekly News, December 18 to 31, 2023
optogenetically functionalized Drosophila dopamine receptors Targeting CB2R in astrocytes for Parkinson's disease
- 📰 GPCR Weekly News, May 13 to 19, 2024
GPCR-related genes analysis Reviews, GPCRs, and more GPR56, an Adhesion GPCR with Multiple Roles in Human Diseases
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
GPCR-Mediated Natural Products and Compounds: Potential Therapeutic Targets for the Treatment of Neurological Disease
- 📰 GPCR Weekly News, February 19 to 25, 2024
A Perspective on Class C GPCR Based Genetically Encoded Biosensors Emergence of lumpy skin disease virus
- 📰 GPCR Weekly News, January 29 to February 4, 2024
Endocrinology, and Taste The role of P2Y6 receptor in the pathogenesis of cardiovascular and inflammatory diseases
- 📰 GPCR Weekly News
Ghrelin receptor signaling in health and disease: a biased view.
- Intermolecular Interactions in G Protein-Coupled Receptor Allosteric Sites at the Membrane Interface
We show that besides classical hydrogen bonds, weak polar interactions such as O-HC, O-Br, and long-range
- 📰 GPCR Weekly News, January 30 to February 5, 2023
The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards
- Odorant receptors – a bit of smell for drug discovery
epithelial cells proliferation via activation by β-ionone which initiates prostate cancer cell cycle arrest (Jones to the diversity of the OR family it will be critical to select potential targets to modulate in a disease
- Decoding β-Arrestins: from Structure to function
the promise of unveiling novel insights into cellular signaling and its implications for health and disease
- Adhesion GPCR Consortium Newsletter - May 2024
will likely bring together some of the hottest adhesion GPCR research going on right now and set the tone Of course, there is the famous parade popularized by the James Bond movie Spectre.
- Overview of adhesion GPCRs self-activation
domain through an auto-catalysis process generating two peptides that are held together by non-covalent bonds
- Nanobodies: New Dimensions in GPCR Signaling Research
Schiff base, and prevents protein degradation, potentially offering therapeutic benefits for retinal diseases6